STAT+: Steve Ubl to step down as CEO of PhRMA
Why it matters: PhRMA will seek new leadership amidst ongoing legislative battles over drug pricing and industry influence.
- Steve Ubl is stepping down as the CEO of PhRMA.
- Ubl led PhRMA through the challenges of the COVID-19 pandemic.
- His leadership also involved confronting numerous efforts from both Democrats and Republicans aimed at reining in drug prices.
Steve Ubl is stepping down as CEO of PhRMA, concluding a tenure marked by navigating the pharmaceutical industry through the COVID-19 pandemic and significant bipartisan legislative pushes to control drug prices.
